|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.78 CNY | +0.61% |
|
-2.89% | +3.48% |
Suzhou Zelgen Biopharmaceuticals Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 197.89 million compared to CNY 98.58 million a year ago. Net loss was CNY 363.75 million compared to CNY 292.67 million a year ago.
Basic loss per share from continuing operations was CNY 1.52 compared to CNY 1.22 a year ago. Diluted loss per share from continuing operations was CNY 1.52 compared to CNY 1.22 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.48% | 1.99B | |
| +37.47% | 727B | |
| -7.88% | 354B | |
| +15.60% | 328B | |
| -0.44% | 277B | |
| +13.47% | 243B | |
| +7.35% | 205B | |
| -6.42% | 203B | |
| +3.86% | 164B | |
| -2.00% | 164B |
SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD. 
